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Abstract
West Nile virus NS4B is a small hydrophobic nonstructural protein approximately 27 kDa in size 
whose function is poorly understood. Amino acid substitutions were introduced into the NS4B 
protein primarily targeting two distinct regions; the N-terminal domain (residues 35 through 60) 
and the central hydrophobic domain (residues 95 through 120). Only the NS4B P38G substitution 
was associated with both temperature-sensitive and small-plaque phenotypes. Importantly, this 
mutation was found to attenuate neuroinvasiveness greater than 10,000,000-fold and lower 
viremia titers compared to the wild-type NY99 virus in a mouse model. Full genome sequencing 
of the NS4B P38G mutant virus revealed two unexpected mutations at NS4B T116I and NS3 
N480H (P38G/T116I/N480H), however, neither mutation alone was temperature sensitive or 
attenuated in mice. Following incubation of P38G/T116I/N480H at 41 °C, five mutants encoding 
compensatory substitutions in the NS4B protein exhibited a reduction in the temperature-sensitive 
phenotype and reversion to a virulent phenotype in the mouse model.
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Introduction
West Nile virus (WNV) is a mosquito-transmitted member of the genus Flavivirus, family 
Flaviviridae. This genus includes other mosquito-borne viruses of public health importance: 
yellow fever virus (YFV), Japanese encephalitis virus (JEV), and the four dengue viruses 
(DENV-1–DENV-4). The WNV genome is a single-stranded, positive-sense RNA molecule 
approximately 11 kb in length encoding a single polyprotein that is co- and post-
translationally cleaved by a combination of viral and host proteases to produce three 
structural (C, prM, and E) and seven nonstructural (NS) proteins (NS1, NS2A, NS2B, NS3, 
NS4A, NS4B, and NS5) (Brinton, 2002; Mukhopadhyay et al., 2005). While two of the 
nonstructural proteins, the NS5 polymerase and NS3 protease, have been relatively well-
characterized, the structure and function of the remaining nonstructural proteins, NS1, 
NS2A, NS2B, NS4A, and NS4B, remain poorly defined (Khromykh et al., 1999; 
Mastrangelo et al., 2007). Within the family Flaviviridae, WNV NS4B exhibits 
approximately 35% amino acid identity with other mosquito-borne flaviviruses (Umareddy 
et al., 2006), such as YFV and members of the DENV serogroup (Fig. 1A). Amino acid 
identities are higher with more closely related viruses such as St. Louis encephalitis virus 
(SLEV) and JEV with values of 56% and 65%, respectively. The most genetically divergent 
WNV isolate, known as Rabensburg virus, displays 88% amino acid identity with NY99 
WNV in NS4B (Bakonyi et al., 2005). Accumulation of NS4B in the perinuclear region 
along with induction of membrane proliferation has been described in WNV (subtype 
Kunjin)-infected cells, and there is evidence that NS4B can translocate into the nucleus 
(Westaway et al., 1997). Flaviviral NS4B was also found to inhibit the interferon-signaling 
cascade at the level of nuclear STAT phosphorylation and has been implicated in 
modulation of the stress-induced unfolded protein response (Ambrose and Mackenzie, 2011; 
Munoz-Jordan et al., 2003, 2005). Amino acid residues in the N-terminal region of the 
WNV NS4B protein have been shown to control interferon resistance in HeLa cells 
expressing subgenomic replicons, although no effect was shown on the expression of full-
length infectious genomes (Evans and Seeger, 2007). NS4B has also been found to co-
localize with other components of the viral replication complex, such as NS3 and double-
stranded RNA (Miller et al., 2006). Sequential processing of the 2 K signal fragment 
between the NS4A and NS4B proteins is thought to be critical for the induction of 
cytoplasmic membrane alterations allowing for replication complex formation and 
maturation of individual proteins (Miller et al., 2007; Preugschat and Strauss, 1991; 
Roosendaal et al., 2006). Secondary structure predictions of the flavivirus NS4B protein 
generated by the consensus ConPredII hydrophobicity plotting program suggest that it is a 
very hydrophobic protein with five transmembrane domains (Arai et al., 2004) (Fig. 1B). 
Experimental evidence suggests that there are three membrane-spanning domains in the 
DENV-2 NS4B protein that are capable of targeting a cytosolic marker protein to 
intracellular membranes while the two N-terminal putative trans-membrane domains 
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predicted by some computer programs may not be biologically significant (Miller et al., 
2006).
Previous studies have described mutations in the NS4B protein of attenuated or passage-
adapted mosquito-borne flaviviruses, including WNV (Davis et al., 2004; Puig-Basagoiti et 
al., 2007), suggesting that this protein plays an important role in replication and 
pathogenesis. In the case of other flaviviruses, a single coding mutation (P101L) in DENV-4 
NS4B conferred a small-plaque phenotype in Aedes albopictus (C6/36) cells, while at the 
same time increasing plaque size in mammalian Vero and Huh-7 cells two-fold and three-
fold, respectively, when assayed via immunoperoxidase staining (Hanley et al., 2003). 
Subsequent studies have suggested that DENV-4 NS4B interacts with the NS3 protease and 
that the P101L substitution ablates this interaction (Umareddy et al., 2006). Pletnev et al. 
described DENV-4 NS4B T105I and L112S substitutions that occurred in a chimeric virus 
expressing WNV structural proteins in a DENV-4 backbone (Pletnev et al., 2002). Blaney et 
al. identified a NS4B L112F mutation in a DENV-4 passaged in Vero cells, while the live 
attenuated JEV vaccine strain SA14-14-2 has an I106V substitution in NS4B (Blaney et al., 
2003; Ni et al., 1995). A hamster viscerotropic Asibi strain of YFV, generated by seven 
passages through hamsters, accumulated seven amino acid substitutions in the polyprotein, 
including a V98I substitution in NS4B (McArthur et al., 2003). Interestingly, YFV vaccine 
strains also display a mutation in NS4B at I95M (Hahn et al., 1987; Wang et al., 1995). 
When the NS4B proteins from different flaviviruses are aligned, it becomes clear that these 
mutations are all located in a similar central hydrophobic region of the protein (Fig. 1A).
In this study, amino acid substitutions were engineered into either the central hydrophobic 
region of the WNV NY-99 strain NS4B protein or an N-terminal motif that is highly 
conserved in both tick-borne and mosquito-borne flaviviruses. In total, eight amino acid 
substitutions were engineered into distinct regions of the WNV NS4B protein. While most 
mutations had no detectable effect on the phenotypic properties examined, the mutant 
containing a P38G substitution was found to confer a small-plaque phenotype in cell culture 
and attenuation of the neuroinvasive phenotype in mice.
Results
Design of amino acid substitutions
The alignment in Fig. 1A shows a series of highly conserved amino acids in the N-terminal 
portion of NS4B from both mosquito- and tick-borne flaviviruses. For WNV these residues 
corresponded to D35, P38, W42, and Y45. The W42 and Y45 residues are perfectly 
conserved in all mosquito- and tick-borne flaviviruses based on available sequence data. The 
D35 residue is found in every mosquito- or tick-borne flavivirus examined except for the 
Brazilian mosquito-borne flaviviruses Ilheus and Rocio, which encoded an alanine and 
glutamic acid residue, respectively (Kuno and Chang, 2005). The P38 residue is conserved 
in every flavivirus examined except for Ilheus virus, which encoded an alanine at this 
residue. Utilizing the ConPredII consensus topology modeling program, the WNV P38 
residue is predicted to reside near the junction of an endoplasmic reticulum lumenal and 
transmembrane domain (Arai et al., 2004). To determine the importance of these residues in 
viral multiplication and virulence phenotypes, D35E, P38G, W42F, and Y45F mutations 
Wicker et al. Page 3













were engineered into the WNV NS4B protein via site-directed mutagenesis of an infectious 
clone. Amino acid substitutions were selected on the basis of a combination of either 
conservative substitutions or substitutions identified in one or more strains of different 
flaviviruses at the specific residue.
Previous studies have described amino acid substitutions in a central hydrophobic region of 
NS4B in either attenuated or passage-adapted flavivirus strains (Hanley et al., 2003; 
McArthur et al., 2003; Wicker et al., 2006). Examination of alignments of various flaviviral 
NS4B amino acid sequences (Fig. 1A), revealed that these mutations all localized to a 
distinct region, residues 95–120. While amino acid identities of flaviviruses were variable in 
this region, there was a high concentration of hydrophobic residues, suggesting that some of 
these residues may interact with intracellular membranes. Amino acid substitutions in WNV 
NS4B were engineered at homologous positions corresponding to published flaviviral NS4B 
mutations. WNV L97M and A100V substitutions corresponded to mutations identified in 
attenuated (M95I) or passage adapted (V98I) YFV strains (Hahn et al., 1987; McArthur et 
al., 2003; Wang et al., 1995). In addition, the engineered WNV NS4B L108P substitution 
was homologous to the DENV-4 P101L mutation found to confer a selective advantage in 
mammalian Vero and Huh7 cells (Hanley et al., 2003). Thus, recombinant WN viruses were 
produced containing individual L97M, A100V, and L108P mutations to determine if 
mutations associated with attenuation of other flaviviruses conferred attenuation of either 
cellular multiplication or mouse virulence phenotypes in WNV. A T116I substitution was 
also introduced following the identification of this additional mutation in a recombinant 
virus encoding a designed P38G substitution to determine its role in observed viral 
phenotypes.
Rescue of recombinant viruses
Utilizing site-directed mutagenesis and the two-plasmid infectious clone of WNV NY99 
(Beasley et al., 2005; Kinney et al., 2006), mutant viruses containing either D35E, P38G, 
W42F, Y45F, L97M, A100V, L108P, or T116I substitutions in the NS4B protein were 
rescued following transfection of Vero cells. Sequencing of the NS4B region of recombinant 
viruses was conducted to confirm the presence of the mutation of interest. No other 
nucleotide changes were identified in any virus, except for P38G virus. Virus stocks 
produced from the initial transfection were used for all subsequent studies with the 
exception of this P38G virus. Following multiple transfection experiments, titers of P38G 
virus were not sufficiently high (approximately 2 log10 pfu/mL) for subsequent studies, so 
this virus was passaged once in Vero cells. Upon sequencing of the NS4B region, the P38G 
virus was found to contain additional NS4B T116I and NS3 N480H substitutions that were 
not present in the original DNA plasmid, so this virus will henceforth be denoted as P38G/
T116I/N480H. A single T116I or N480H substitution was engineered into the WNV 
infectious clone to test the relative contribution towards observed phenotypes of this 
mutation outside the context of the P38G mutation. The T116I mutant displayed a plaque 
phenotype similar to wild type virus. The P38G/T116I/N480H mutant virus was found to 
exhibit a small-plaque phenotype when compared to wild-type or other mutant viruses (less 
than 1 mm versus 4 mm for the parental virus) (data not shown). The N480H mutant 
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displayed an intermediate plaque phenotype compared to the NY99 wild type and P38G/
T116I/N480H viruses.
Temperature sensitivity and multiplication kinetics of recombinant viruses in cell culture
Each recombinant mutant virus was investigated for temperature sensitivity by plaquing in 
Vero cells at both 37 °C and 41 °C. D35E, W42F, Y45F, L97M, A100V, L108P, T116I, and 
N480H mutant viruses and wild-type all showed similar levels of plaquing efficiency at both 
temperatures (Table 1). In contrast, the P38G/T116I/N480H virus was found to exhibit a 3.8 
log10 pfu reduction in efficiency of plaquing at 41 °C compared to 37 °C (Table 1A) while 
there was no reduction in plaquing efficiency in Vero cells at 39.5 °C (data not shown).
Multiplication curves of wild-type WNV NY-99 and the mutant viruses were compared at a 
moi of 0.01 in Vero cells at both 37 °C and 41 °C (Fig. 2). In addition, multiplication curves 
of recombinant viruses in mouse neuroblastoma Neuro2A at 37 °C and mosquito C6/36 cells 
at 28 °C were undertaken (data not shown). All mutant viruses were indistinguishable from 
wild-type virus in each cell line tested with the exception of the P38G/T116I/N480H virus. 
The P38G/T116I/N480H virus exhibited a significant delay in multiplication in Vero cells at 
41 °C, but not at 37 °C (Figs. 2A and 2C). Infectivity titers for the P38G/T116I/N480H virus 
at 41 °C were also significantly lower than those for wild-type virus at every time point 
except 96 h. The P38G/T116I/N480H virus showed no differences in multiplication kinetics 
from wild-type virus in Neuro2A and C6/36 cells at the temperatures tested (data not 
shown).
P38G/T116I/N480H virus is attenuated for neuroinvasiveness but not neurovirulence in 
mice
We have previously described a mouse model to investigate neuroinvasiveness and 
neurovirulence of WNV via inoculation of 3–4 week-old female NIH Swiss mice 
intraperitoneally (ip) or intracerebrally (ic), respectively (Beasley et al., 2002). With the 
exception of the P38G/T116I/N480H virus, all recombinant viruses were as virulent as wild-
type WNV following ip inoculation in terms of lethality and average survival time (Table 1). 
The P38G/T116I/N480H mutant was attenuated for neuroinvasiveness with an ip LD50 
value of greater than 10,000 pfu. However, when inoculated via the ic route, the P38G/
T116I/N480H mutant remained as lethal as wild-type WNV with an ic LD50 value of less 
than 0.1 pfu.
The P38A substitution maintained a neuroinvasive phenotype in mice
Following identification of the attenuated P38G/T116I/N480H virus, a P38A amino acid 
substitution was introduced into the WNV infectious clone to better elucidate the importance 
of the P38 residue in the absence of other amino acid mutations. The P38 residue is 
conserved in both mosquito- and tick-borne flaviviruses except for Ilheus virus, which 
encoded an alanine at this residue (Fig. 1A). Recombinant mutant WNV encoding the P38A 
substitution was not temperature sensitive and exhibited a mouse neuroinvasive phenotype 
comparable to wild-type WNV (Table 1A).
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Multiplication of P38G/T116I/N480H virus in mice
Multiplication kinetics were compared in mice following ip inoculation of either 100 pfu 
wild-type WNV or 100 pfu P38G/T116I/N480H mutant in the NIH Swiss mouse model to 
determine serum and brain infectivity titers for these viruses. The peak viremia for wild-type 
WNV occurred on day 2 post-inoculation and reached 5.0 log10 pfu/mL, while the peak titer 
for the P38G/T116I/N480H virus was 3.1 log10 pfu/mL, also on day 2 post-inoculation 
(Table 2). Peak brain titers reached 6.8 log10 pfu for the wild-type virus on day 6 post-
inoculation while virus infection was never detected in the brains of P38G/T116I/N480H 
infected mice. The limit of detection was 1.7 log10 pfu/mL for serum and 2.7 log10 pfu/brain 
for the brain. RT-PCR amplification was conducted on RNA isolated from mouse brain on 
day 6, when high titers of wild-type WNV were detected in the brain. No PCR product was 
detected for WNV RNA from brains of mice infected with P38G/T116I/N480H virus, while 
the brains of mice infected with wild-type virus were positive for viral RNA (data not 
shown). Thus, while the P38G/T116I/N480H virus exhibited detectable serum infectivity 
titers, there was no evidence the virus ever invaded the brain.
Isolation of P38G/T116I/N480H derivatives encoding compensatory mutations
As shown in Fig. 2C, the P38G/T116I/N480H virus exhibited delayed multiplication in Vero 
cells at 41 °C with infectivity titers finally approaching those of wild-type virus by 96 h 
post-infection. Given that a pattern characteristic of delayed multiplication was observed, a 
virus sample from the 96-hour time point was investigated to test for the selection of virus 
that was either a revertant or contained compensatory mutations. Serial dilutions of P38G/
T116I/N480H-derived virus grown in Vero cells at 41 °C from the 96-hour time point were 
inoculated via the ip route into female three-week-old NIH Swiss mice to test for virulence 
characteristics of the virus. Sporadic mortality was observed at multiple doses of virus (less 
than 50% mortality per dose), and no dose was associated with either uniform mortality or 
survival. Brains were taken from four representative mice that had clinical signs of WNV 
disease, and viral RNA was isolated and sequenced. Upon sequencing of the NS4B region, 
viral RNA from two of the mice was found to encode an additional NS4B A95T substitution 
in addition to the original P38G and T116I substitutions. Viral RNA from the brain of a third 
mouse encoded an additional NS4B V110A mutation while viral RNA isolated from the 
fourth mouse brain encoded an additional I224V mutation. Upon analysis of the consensus 
sequencing chromatogram from the original 96-hour 41 °C virus sample, heterogeneity was 
observed at nucleotides G/A7198 corresponding to residue 95 and T/C7244 corresponding 
to residue 110, but not at position A7585 corresponding to residue 224, indicating a mixed 
population of viruses at the 96-hour time point following incubation in Vero cells at 41 °C 
(data not shown).
To identify any additional mutations within the NS4B region that may have been selected 
during multiplication at 41 °C, eight plaques were harvested from virus at the 96-hour time 
point at 41 °C. Nucleotide sequencing of the NS4B region of these eight plaques revealed 
four isolates encoding the I224V substitution, and one isolate each encoding the following 
substitutions: A83S, A95T, A100V, and V110A. Thus, A95T, V110A, and I224V 
substitutions were identified both in plaque picks from the 96-hour time point sample in cell 
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culture and in mouse brain, while A83S and A100V substitutions were identified only by 
plaque picking. Virus encoding either a direct G38P or I116T reversion was never detected.
Analysis of compensatory mutants
Viruses containing the engineered P38G/T116I/N480H substitutions in addition to a putative 
compensatory substitution (i.e., either A83S, A95T, A100V, V110A, or I224V) were 
analyzed to determine if the temperature-sensitive and/or mouse neuroinvasive-attenuated 
phenotypes of the parental virus were conserved. Viruses encoding A95T, A100V, V110A, 
or I224V substitutions in addition to P38G/T116I/N480H were found to be no longer 
temperature-sensitive in Vero cells at 41 °C with less than a 1 log10 decrease in titer at 41 °C 
compared to 37 °C, but all multiplied to a lower titer than the wild-type virus at 37 °C 
(Table 3). The P38G/T116I/N480H + A83S virus was found to be slightly temperature-
sensitive with a 1.3 log10 pfu/mL decrease in titer 41 °C versus 37 °C, although this virus 
was less temperature-sensitive than the parental P38G/T116I/N480H virus and below the 2.0 
log10 pfu/mL decreased level denoted as significant. Viruses encoding the putative 
compensatory substitutions in addition to the P38G/T116I/N480H substitutions were 
inoculated into three-week-old female NIH Swiss mice via the ip route. Viruses encoding 
additional A95T, A100V, V110A, and I224V substitutions were found to exhibit mouse-
neuroinvasive virulent phenotypes with ip LD50 values greater than one million-fold lower 
than observed for the attenuated P38G/T116I/N480H parental virus (Table 3). The P38G/
T116I/N480H/A83S virus was found to retain an attenuated phenotype with an ip LD50 
value of greater than 1000 pfu. Each P38G/T116I/N480H-derived virus that encoded an 
additional NS4B compensatory substitution was subjected to complete genomic sequencing, 
and each virus had the A6049C nucleotide change encoding an NS3 N480H amino acid 
substitution.
Mutation rate of the NS4B gene of P38G/T116I/N480H virus when passaged in Vero cells at 
37 °C or 41 °C
To better understand the significance of the observed compensatory substitutions, viral RNA 
was isolated from the parental P38G/T116I/N480H virus that had been passaged once in 
Vero cells post-transfection plus virus samples taken from Vero cell supernatants at 96 h 
post-infection at 37 °C and 41 °C. Viral RNA was subjected to RT-PCR utilizing NS4B-
specific primers, and PCR products were sequenced directly to obtain the consensus 
sequence. In addition, PCR products were cloned and 21–23 clones were sequenced for each 
product to assay the prevalence of nucleotide changes and deduced amino acid substitutions. 
The basal variability of the parental P38G (nucleotide substitutions C7027G and C7028G)/
T116I (nucleotide substitution C7262T) viral RNA was analyzed and compared to the 
selection of specific mutants following 96 h in Vero cells at either 37 °C or 41 °C. Cloned 
PCR fragments from the parental P38G/T116I/N480H virus were found to exhibit few 
differences with 3/22 (14%) sequenced fragments exhibiting nucleotide changes and 1/22 
(5%) fragment encoding an amino acid substitution (Table 4). Two parental cDNA clones 
exhibited silent nucleotide changes, and a single cDNA clone encoded a H58Y (C7087T) 
amino acid substitution. In contrast, 22/23 (96%) cDNA clones from the 96-hour 41 °C virus 
sample exhibited nucleotide changes leading to amino acid substitutions. Fifteen of 23 
(65%) sequenced clones encoded the A95T (G7198A) substitution, 4/23 (17%) encoded the 
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A100V (C7214T) substitution, 2/23 (9%) encoded the I224V (A7585G) substitution, and 
1/23 (4%) encoded a R84Q (G7166A) substitution. In addition, T48A (A7057G), L56P 
(T7056C), V155I (G7378A), I168V (A7414G), and C227R (T7594C) substitutions were 
each detected in one cDNA clone (4% prevalence) from the 96-hour 41 °C virus and 
occurred in conjunction with either an A95T or A100V substitution (Table 4). Seven of 23 
(30%) cDNA clones exhibited additional silent nucleotide changes in addition to encoding 
amino acid substitutions. Sequenced cDNA clones from the 96-hour 37 °C virus sample 
yielded an intermediate frequency of substitutions with 7/21 (33%) exhibiting nucleotide 
changes and 5/21 (24%) encoding amino acid substitutions. Two of 21 (10%) clones were 
found to encode T109A (A7240G) and I245V (A7648G) substitutions. One clone of 21 
(5%) encoded a V217I (G7564A) substitution, and another (1/21; 5%) encoded a N189S 
(A7481G) substitution. Finally, one clone (5%) was found to lack the parental T116I 
substitution, but this clone encoded an additional M177L (A7444T) substitution. Overall, a 
total of 50 nucleotide changes were found in 66 cDNA clones that were sequenced, and 
49/50 (98%) were transition mutations. The single A7444T transversion led to the deduced 
M177L amino acid substitution in the only fragment lacking the parental T116I (C7262T) 
substitution. Three of 50 (6%) nucleotide changes occurred in cDNA clones from the 
parental virus, 36/50 (72%) occurred in clones from the 96-hour 41 °C virus, and 11/50 
(22%) occurred in clones from the 96-hour 37 °C virus.
RNA and protein levels in wild-type and P38G/T116I/N480H virus-infected Vero cells
To investigate the block in viral replication with respect to the multiplication of P38G/
T116I/N480H virus at 41 °C, intracellular viral RNA and protein levels were assayed in 
Vero cells at both 37 °C and 41 °C. Quantitative real-time RT-PCR indicated that levels of 
viral RNA synthesis for both wild-type and P38G/T116I/N480H viruses were within 100-
fold of each other in Vero cells at 37 °C during all time points (Fig. 3A, left panel). In 
contrast, there was a sharp reduction in synthesis of viral RNA levels in P38G/T116I/N480H 
virus-infected cells compared to wild-type virus-infected cells (decreases between 1000-fold 
and 10,000-fold) at 41 °C (Fig. 3A, right panel). Viral protein levels were measured by 
Western blot utilizing a rabbit anti-WNV E protein domain III antiserum to probe cell 
lysates generated from virus-infected Vero cells. Viral E protein (~50 kDa band) levels for 
both wild-type and P38G/T116I/N480H virus-infected cells were similar at 37 °C, while 
viral protein levels were sharply reduced in P38G/T116I/N480H virus-infected cells 
compared to wild-type virus-infected cells at 41 °C (Fig. 3B). β-actin (~45 kDa band) was 
used as an internal standard, and these protein levels were similar in all samples.
Discussion
In this study we have investigated the role of various amino acid substitutions in the NS4B 
protein and their role in a number of phenotypic properties of WNV. These engineered 
mutations were focused on a highly conserved N-terminal motif and a central hydrophobic 
region. Targeted N-terminal residues are highly conserved throughout both tick-borne and 
mosquito-borne flaviviruses. In contrast, those targeted to the central hydrophobic region are 
less conserved and exhibit significant variability throughout the Flavivirus genus, but have 
been reported to be involved in phenotypic properties of other flaviviruses. In particular, 
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there is evidence to suggest that the central region of NS4B plays a role in the virulence 
phenotype of flaviviruses (Hanley et al., 2003; McArthur et al., 2003; Wicker et al., 2006). 
Most engineered substitutions were well-tolerated, even those corresponding to positions 
found to confer altered growth phenotypes in other flaviviruses. Only one of nine 
recombinant mutant viruses tested exhibited an attenuated phenotype in mice. This mutant, 
containing an engineered P38G substitution and an additional T116I substitution, was found 
to exhibit small-plaque morphology, temperature sensitivity at 41 °C, and attenuation of 
neuroinvasiveness in mice.
The P38G/T116I/N480H mutant exhibited at least 10,000,000-fold attenuation for 
neuroinvasiveness when inoculated via the ip route, yet was as neurovirulent as wild-type 
WNV when injected via the ic route. Previously, we reported a recombinant WNV virus 
containing an NS4B C102S substitution that was highly attenuated for both 
neuroinvasiveness and neurovirulence (Wicker et al., 2006). The difference in 
neurovirulence phenotypes between the two attenuated mutants implies that mouse 
neuroinvasiveness and neurovirulence phenotypes are encoded by different molecular 
determinants. In addition, while the P38G/T116I/N480H virus exhibited small-plaque 
morphology, the C102S virus had a large-plaque phenotype. Both viruses were found to be 
temperature-sensitive at 41 °C although the phenotype was more severe with the C102S 
virus. The C102 residue resides within the central hydrophobic region that was also targeted 
in this study suggesting that while most substitutions are well-tolerated, some can 
significantly alter virulence and multiplication phenotypes.
The engineered P38G substitution is primarily responsible for observed differences in 
phenotypes as mutants containing NS4B T116I (Table 1A) or NS3 N480H (Table 1B) alone 
exhibited multiplication and virulence phenotypes similar to those of wild-type WNV, as did 
the mutants encoding additional NS4B compensatory substitutions (Table 3). The viremia 
curve showed that the P38G/T116I/N480H virus attained significant serum titers but did not 
successfully invade the brain (Table 2). It is hypothesized that the attenuated mutant never 
reached sufficiently high titers to cross the blood–brain barrier. This is further supported by 
the observation of a highly neurovirulent phenotype following ic inoculation of the P38G/
T116I/N480H mutant demonstrating that this virus is fully capable of causing disease 
following introduction into the central nervous system. Virulent WNV strains have 
previously been associated with increased viremias and mortality in crows, while attenuated 
viruses tend to produce lower viremias and concurrent increases in survival (Brault et al., 
2007; Kinney et al., 2006). However, it has also been demonstrated that WNV infections 
successfully crossing the blood–brain barrier do not always result in significant mortality in 
mice (Brown et al., 2007; Wicker et al., 2006).
Given that virus encoding only the P38G substitution was never isolated following multiple 
transfection attempts, an additional substitution (such as T116I) may be required for the 
viability of the virus. To further address this possibility, a P38A substitution was engineered. 
The resulting recombinant virus did not encode T116I or any additional substitutions, nor 
did it encode temperature sensitive or mouse attenuated phenotypes. This was expected as 
the Brazilian flavivirus Ilheus encodes an alanine at the homologous residue suggesting that 
this substitution would be tolerated (Figueiredo, 2000). It is possible that increased 
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flexibility introduced by the glycine residue near the putative N-terminal membrane 
insertion point (see Fig. 2) disrupted the normal conformation provided by proline while the 
alanine substitution may preserve the natural conformation thereby ablating the need for 
additional compensatory substitutions. In addition it was found that the attenuated 
phenotype conferred by the P38G substitution could be compensated by a variety of 
additional substitutions. Multiplication of the P38G/T116I/N480H virus at 41 °C resulted in 
identification of variants containing compensatory mutations at the 96-hour time point 
sample. Viruses containing A95T, A100V, V110A, or I224V substitutions in addition to the 
original P38G and T116I substitutions exhibited mouse virulence characteristics similar to 
wild-type WNV and were no longer temperature-sensitive. However, a virus containing an 
additional A83S substitution was still attenuated for neuroinvasiveness in mice and 
exhibited a temperature-sensitive phenotype in Vero cells at 41 °C; although this virus was 
less temperature-sensitive than the parental P38G/T116I/N480H virus. These data suggest 
that the same underlying mechanism may be responsible for both the temperature-sensitive 
phenotype in cell culture and the neuroinvasive phenotype in mice. Full-length genomic 
sequencing was conducted on the P38G/T116I/N480H virus as well as P38G/T116I/N480H 
derived strains encoding compensatory substitutions, and only the NS3 N480H mutation 
was observed outside of the NS4B region. While the attenuated phenotype of the P38G/
T116I/N480H virus was reversed by a variety of compensatory mutations, a direct G38P 
revertant was never detected; rather, the engineered substitution appeared to be quite stable. 
This is presumably due to the engineered glycine differing from proline by two adjacent 
transversion nucleotide changes (C7027G and C7028G), such that direct reversion would be 
a rare event. Interestingly, the proline did not mutate to an alanine, which would only 
require a single nucleotide change, however, this may be due to the presence of the T116I 
substitution. This is in marked contrast to the previously described C102S (G7220C) virus, 
where direct S102C (C7220G) revertants (a single nucleotide change) were associated with 
reversal of temperature-sensitive and mouse attenuation phenotypes (Wicker et al., 2006). 
Each of the compensatory mutations associated with the engineered P38G virus (A83S 
(G7162T), A95T (G7198A), A100V (C7214T), V110A (T7244), T116I (C7262T), I224V 
(A7585G)) represents a single nucleotide change. It is not entirely clear how the 
compensatory substitutions exert their effects. None of the compensatory mutations were 
highly conserved among the mosquito-borne flaviviruses. The NS4B A83S substitution has 
been found to occur naturally in a WNV strain isolated from human plasma in Ohio in 2002 
(Davis et al., 2005). In addition, the related naturally mouse-attenuated Rabensburg virus 
differs from the NY99 strain of WNV at positions A95S, A100V, and T116A (Bakonyi et 
al., 2005). A lineage 2 isolate from Nigeria also encodes A100V and T116A substitutions 
while an attenuated lineage 2 strain from Madagascar (MAD78) encodes the T116I 
substitution, although it is unlikely that this mutation is directly responsible for the 
attenuation of the virus (Keller et al., 2006; Yamshchikov et al., 2001). In contrast, the V110 
and I224 residues are highly conserved in all WNV isolates analyzed to date but not in other 
members of the JE serogroup.
Putative compensatory substitutions such as T116I, M177L, A95T, A100V, V100A, and 
I224V may restore the ability of the NS4B protein to assemble and function properly. Yu et 
al. have shown that there are molecular determinants in both N-terminal and C-terminal 
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regions of the Hepatitis C virus (HCV) NS4B protein that may influence the ability of NS4B 
to polymerize (Yu et al., 2006). In addition, it has been shown that substitutions in predicted 
ER-lumenal regions of the NS4B protein can nearly abolish HCV replicon colony formation 
although these regions are thought to be separate from the cytoplasmic components of the 
replication complex (Lindstrom et al., 2006). This is further support for the hypothesis that 
the NS4B protein may form either oligomers or crucial complexes with certain cellular 
proteins. While HCV NS4B displays little sequence homology with WNV NS4B, it is 
thought that these proteins may exhibit similar topologies and functions within the cell 
(Lundin et al., 2003; Welsch et al., 2007). The P38 residue is predicted to localize to the 
junction of an ER-lumenal region and a transmembrane domain, and it will be critical to 
elucidate potential protein–protein interactions to better explain the temperature sensitive 
and mouse attenuation phenotypes observed in conjunction with disruption of this residue.
The results reported in this study begin to identify the interacting network of residues in 
WNV NS4B that are essential in maintaining the life cycle of wild type NY99 WNV. In the 
absence of atomic structural information of NS4B, one cannot provide an accurate 
interpretation of the current data. However, the data unequivocally establish the presence of 
long range interactions among various putative structural elements in NS4B. Regardless of 
the algorithm used in predicting the secondary structures, including the transmembrane 
domains, there is a consensus that the N-terminal residues reside in the ER lumen and the 
other key residues involved in this study, e.g. 83, 95, 100, 110, 116 and 224, are located in 
transmembrane domain(s) (Miller et al., 2007). Thus, residue 38 obviously resides at a 
distance from the residues that are located in transmembrane domains. It is possible to 
eliminate a direct pairwise interaction between residue 38 and the others as the likely 
mechanism to confer compensatory effects as reported in this study. One possible 
mechanism is the alteration of pairwise interaction between the mutated side-chains and 
other residues between these putative transmembrane domains. The proof of this mechanism 
will require the atomic structure of NS4B. Another possibility is that these side-chain 
substitutions affect the stability of the transmembrane domains (Adamian and Liang, 2001). 
It has been shown that a single amino acid replacement can affect the stability of a 
transmembrane domain and as a consequence leading to a disease state (Li et al., 2006). In 
addition to compensatory mutations observed within the NS4B protein, a NS3 N480H 
substitution was present in all P38G-derived viruses. Second-site mutations have also been 
identified within the NS3 protease region of GBV-B RNAs containing NS4B C-terminal 
HCV amino acid sequences, providing evidence for interaction between NS3 and NS4B 
during replication (Benureau et al., 2010). The dengue NS4B protein has also been shown to 
interact with NS3, and it is possible that the engineered WNV NS4B P38G substitution 
induced the second-site NS3 N480H mutation to preserve the potential for productive 
interaction during replication (Umareddy et al., 2006). Thus, an understanding of the 
molecular mechanism of structure–function correlation of NS4B and potential interactions 
with other host and viral products requires further biophysical studies on the structure and 
energetics among these elements.
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The 3′ plasmid of the WNV infectious clone WN/IC P991 served as the template for 
introduction of mutations (Beasley et al., 2005; Kinney et al., 2006). Mutagenesis was 
conducted using the QuickChange XL Site-Directed Mutagenesis Kit (Stratagene) following 
the manufacturer’s protocol. Sets of primers were designed for each engineered mutation 
(D35E, P38G, P38A, W42F, Y45F, L97M, A100V, L108P, T116I) including sufficiently 
long flanking regions to obtain a predicted melting temperature of at least 78 °C. Primer 
sequences are available upon request. Mutagenesis reactions were carried out in a 
thermocycler following specific cycling parameters listed in the manufacturer’s protocol. 
Products were then digested with DpnI to remove parental DNA and transformed into 
XL-10 Gold ultracompetent cells that were plated on Luria-Bertani/ampicillin plates. Four 
colonies from each mutagenesis reaction were isolated, and plasmid DNA was purified 
utilizing the GenElute Plasmid Miniprep kit (Sigma). Sequencingwas conducted to 
confirmthe presence of the desiredmutation and absence of additional mutations in the 
NS4B gene. Appropriate plasmids were grown in 200 mL cultures to obtain concentrated 
DNA for further manipulation.
Construction and transfection of recombinant viruses
The WNV NY-99 infectious clone was constructed in two plasmids (Beasley et al., 2005; 
Kinney et al., 2006). Three micrograms each of 5′ pWN-AB and 3′ pWN-CG infectious 
clone plasmids were digested simultaneously with NgoMIV and XbaI restriction enzymes 
(New England Biolabs). Appropriate DNA fragments were visualized on an agarose gel and 
purified using a Qiaquick gel extraction kit (Qiagen). Fragments were ligated overnight at 
room temperature using T4 DNA ligase (NEB). DNA was linearized by digesting with XbaI, 
treated with Proteinase K (Roche), and extracted twice with phenol/chloroform/isoamyl 
alcohol and once with chloroform. DNA was ethanol precipitated, and the pellet was 
resuspended in TE buffer. The resulting product served as the template for transcription 
using a T7 Ampliscribe kit (Epicentre) and A-cap analog (NEB). Following a 3-hour 
incubation at 37 °C, the transcription reaction was added to 1.5 × 107 African green monkey 
kidney Vero cells suspended in 500 μL PBS, and transfection was accomplished using 
electroporation. The cells were placed in a cuvette (0.2 cm electrode gap) on ice, pulsed 
twice at 1.5 kV, infinite Ohms, and 25 μF, incubated at room temperature for 10 min, 
transferred to 75-cm2 flasks containing MEM with 8% FBS, and incubated at 37 °C and 5% 
CO2. Viruses were harvested on day 5 or 6 post-transfection, when CPE was evident. 
Culture medium containing virus was clarified by centrifugation for 5 min at 12,000 g, and 
1-mL aliquots were stored at −80 °C. Viral RNA was extracted using the QIAamp Viral 
RNA Mini-Spin kit (Qiagen). The presence of the engineered NS4B mutation was 
confirmed by amplifying the NS4B region using the Titan One-Step RT-PCR kit (Roche) 
and DNA sequencing. Full-length genomic sequencing was conducted of the P38G/T116I/
N480H mutant virus to check for additional mutations.
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Plaque and temperature sensitivity assays
Infectivity titers of recombinant viruses were determined by plaque titration in Vero cells at 
both 37 °C and 41 °C. Vero cells were allowed to grow to approximately 90% confluency in 
six-well plates. Growth medium (MEM with Earle’s salts and L-glutamine (Gibco) 
supplemented with 8% fetal bovine growth serum (FBS) (Hyclone), 100 units/mL penicillin 
(Gibco), and 100 μg/mL streptomycin (Gibco) was removed, and cells were rinsed with 
phosphate buffered saline (PBS-Gibco). Serial dilutions of each virus were adsorbed, 200 μL 
per well, for 30 min before overlaying the cell monolayer with a 50:50 mixture of 2% agar 
(Sigma) and 2× MEM (Gibco) containing 4% FBS. Two days following the first agar 
overlay, 2 mL of a mixture of 2% agar and 4% FBS 2× MEM containing 2% neutral red was 
added to each well. Plaques were visualized and counted the following day, and viral 
infectivity titers were calculated. Viruses found to be temperature sensitive at 41 °C (i.e., a > 
100-fold reduction of efficiency of plaquing compared to that at 37 °C) were plaqued at 39.5 
°C to better define the temperature sensitive phenotype.
Mouse virulence studies
Recombinant viruses were diluted in PBS, and 10-fold serial doses ranging from 103 pfu to 
10−1 pfu were injected by ip route in a volume of 100 μL into groups of five 3–4 week old 
female NIH Swiss mice (Harlan). Clinical signs of infection such as ruffled fur or hunched 
posture were noted during the following 14 days, and the LD50 value was calculated for 
each virus. Three weeks following inoculation, surviving mice were challenged 
intraperitoneally with a uniformly lethal dose (100 LD50) of wild-type NY-99 WNV to 
determine if they had developed a protective immune response. If a virus was found to be 
attenuated via the ip route, serial 10-fold doses were administered to isofluorane 
anesthetized 3–4 week old mice in a 20μL volume via the intracerebral (ic) route to 
investigate the mouse neurovirulence phenotype.
Virus multiplication in cell culture
Growth curves were conducted for wild-type WNV and the mutant viruses in monkey 
kidney Vero cells at both 37 °C and 41 °C, in mouse neuroblastoma Neuro2A cells at 37 °C, 
and in mosquito C6/36 cells at 28 °C. Cells were grown in six-well plates in appropriate 
media and were infected with 200 μL of virus diluted in PBS at a moi of 0.01. After 
adsorbing virus for 30 min, the cells were washed three times with PBS, and 4 mL of the 
appropriate medium was added. At various timepoints following infection, 0.5 mL samples 
were removed and frozen at −80 °C. The harvested samples were then plaque titrated in 
twelve-well plates of Vero cells. Vero cells were grown in MEM with Earle’s salts and L-
glutamine (Gibco) supplemented with 8% FBS, 100 units/mL penicillin, and 100 μg/mL 
streptomycin. Neuro 2A cells were grown in MEM with Earle’s salts and L-glutamine 
supplemented with 8% FBS, 100 units/mL penicillin, 100 μg/mL streptomycin, 0.075% 
sodium bicarbonate (Sigma), and 1 mM sodium pyruvate (Sigma). C6/36 cells were grown 
in MEM with Earle’s salts and L-glutamine supplemented with 8% FBS (Hyclone), 100 
units/mL penicillin, 100 μg/mL streptomycin, and 0.075% tryptose phosphate broth.
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Virus multiplication in mice
Female 3–4 week old NIH Swiss mice were inoculated with 100 pfu of either wild-type 
WNV or P38G/T116I/N480H virus via the ip route. Three mice were sacrificed for each 
virus per day for 6 days. Blood was collected by cardiac puncture, and brains were 
harvested. Brains were homogenized by repeated pipetting in 0.5 mL MEM media 
supplemented with 8% FBS, and centrifuged homogenate supernatants were subjected to 
plaque assays to determine infectivity titers in the brain. The limit of detection was 2.7 log10 
pfu/brain. Viral RNA was also isolated from brains using the Viral RNA Mini Spin kit 
(Qiagen) and amplified by RT-PCR utilizing the Titan kit (Roche) to detect low levels of 
virus in the brain below the level of detection for plaque assays. Blood from cardiac 
puncture was spun down, and serum was removed and frozen. Serum samples were plaque 
assayed to determine viral titers, and the limit of detection was 1.7 log10 pfu/mL.
Analysis of quasispecies in viral-RNA with respect to compensatory substitutions
Viral RNA was isolated from the parental P38G/T116I/N480H viral stock in addition to 
virus samples from the 96-hour time point in Vero cells incubated at either 37 °C and 41 °C 
utilizing the Qiagen RNeasy mini kit. RT-PCR was conducted on the 96-hour time point 
samples utilizing the Titan RT-PCR kit (Roche) and NS4B-specific primers, and PCR 
products were cloned into the T-easy vector (Promega). Resulting plasmids were 
transformed into E. coli DH5α cells and selected on LB/ampicillin plates. Twenty-one to 23 
colonies each were picked from the parental sample used to infect Vero cell cultures, 96-
hour 37 °C sample, and 96-hour 41 °C sample. The NS4B region was sequenced for each 
cDNA clone, and frequencies of nucleotide and encoded amino acid substitutions for the 
cDNA clones from each of the three samples were determined.
Quantitative real-time RT-PCR and Western blots
Virus-infected Vero cell monolayers (moi of 0.01) were rinsed three times with PBS, and 
total viral and cellular RNA was isolated from cellular lysates at 0, 12, 24, and 48 h post-
infection by using the Qiagen RNeasy Mini kit. A ~100-bp fragment of the 3′ noncoding 
region was amplified using TaqMan one-step RT-PCR as described by Vanlandingham et al. 
(2004) using a primer set first described by Lanciotti et al. (2000). RNA levels were 
quantified by comparison to a standard curve generated from serial 10-fold dilutions of 
WNV RNA isolated from a virus stock of known infectivity titer resulting in values 
expressed as pfu equivalents. To determine protein levels, cell lysates were generated by 
solubilizing virus- or mock-infected Vero monolayers in 0.5 mL of RIPA buffer containing 
1% SDS. Equal volumes (8 μL) of each lysate were run in 12.5% SDS-PAGE gels and 
transferred to PVDF membranes in duplicate. One membrane was probed with rabbit 
polyclonal anti-WNV envelope domain III antibody to determine viral E protein levels, 
while the other membrane was probed with mouse anti-β-actin antibody (Sigma) to assay 
cellular protein levels.
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Primary amino acid sequence of NS4B proteins from different flaviviruses and predicted 
secondary structure of WNV NS4B. (A) Complete NS4B amino acid alignments including 
both tick-borne and mosquito-borne flaviviruses show locations of introduced substitutions 
in the conserved N-terminal region (D35E, P38G, W42F, Y45F) and central hydrophobic 
domain (L97M, A100V, L108P, T116I). Virus abbreviations: WNV: West Nile NY99 strain 
(NC_009942); KUNV: Kunjin (AY274504); RABV: Rabensburg (AY765264); JEV: 
Japanese encephalitis (NC_001437); MVEV: Murray Valley encephalitis (NC_000943); 
USUV: Usutu (NC_006551); SLE: St. Louis encephalitis (NC_007580); ILHV: Ilheus 
(NC_009028); ROCV: Rocio (AY632542); DEN1: dengue 1 (NC_001477); DEN2: dengue 
2 (NC_001474); DEN3: dengue 3 (NC_001475); DEN4: dengue 4 (NC_002640); YFV: 
yellow fever Asibi strain (AY640589); LGTV: Langat (NC_003690); OHFV: Omsk 
hemorrhagic fever (NC_005062); TBEV: Tick-borne encephalitis (NC_001672); POWV: 
Powassan (L06436). (B) A topological model was constructed based on the consensus 
prediction (ConPredII) hydrophobicity plotting program (Arai et al., 2004). Five 
transmembrane domains were predicted, and amino acids 106–126 represent the primary 
transmembrane domain (green). Predicted locations of introduced N-terminal substitutions 
are shown in purple while introduced central hydrophobic substitutions are shown in orange. 
Positions of additional compensatory substitutions (A83S, A95T, A100V, V110A, I224V) 
observed in the P38G/T116I/N480H virus incubated at 41 °C are shown in yellow. *A100V 
and T116I substitutions were introduced as central hydrophobic substitutions but also 
represent compensatory substitutions following introduction of the P38G substitution.
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Multiplication kinetics of recombinant wild-type and N-terminal or central hydrophobic 
mutant viruses in monkey kidney Vero cells. Growth curves were conducted at a MOI of 
0.01, and the limit of detection was ≤0.7 log10 pfu/mL. N-terminal (A) and central 
hydrophobic (B) mutants in Vero cells at 37 °C, N-terminal (C) and central hydrophobic (D) 
mutants in Vero cells at 41 °C.
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Viral RNA (A) and protein (B) levels from cell lysates of wild-type and P38G/T116I/N480H 
mutant infected cell cultures incubated at 37 °C and 41 °C. (A) TaqMan quantitative real-
time RT-PCR was conducted on total cellular RNA preparations using primers localizing to 
the WNV 3′-UTR. Data were converted to pfu equivalents (PEQ) utilizing a standardized 
curve. (B) Protein levels were assayed from crude cellular lysates, and Western blots were 
probed for WNV E protein (~50 kDa band) with rabbit anti-E domain III polyclonal 
antibody. β-actin (~45 kDa band) levels were used as an internal standard.
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Table 1
Mouse virulence and temperature sensitive phenotypes of recombinant wild-type WNV, the central 
hydrophobic mutants, and the N-terminal mutants (A) and the recombinant wild-type WNV, attenuated P38G/







i.p. LD50 (pfu) i.p. AST
(days±SD)
i.c. LD50 (pfu) Viral titer/mL at
37 °C (log10 pfu)
Viral titer/mL at
41 °C (log10 pfu)
Relative change in 
viral titer
[log10 (pfu 41 °C/pfu 
37 °C)]
A
 NY99 0.5 7.4±0.9 <0.1 6.5 6.7 −0.2
 D35E 0.4 7.2±0.9 n.d. 5.7 5.4 −0.3
 P38G/T116I/N480H >10,000 >35 <0.1 6.2 2.4 −3.8
 W42F <0.1 7.4±0.9 n.d. 6.7 6.5 −0.2
 Y45F <0.1 7.4±0.9 <0.1 5.5 5.8 0.3
 L97M 0.4 7.6±1.0 n.d. 6.5 6.8 0.3
 A100V 0.7 7.2±0.4 n.d. 7.0 6.7 −0.3
 L108P <0.1 7.6±1.5 n.d. 6.8 7.0 0.2
 T116I 0.7 8.0±1.8 n.d. 6.9 7.0 0.1
 P38A 7 8.6±1.5 n.d. 5.8 5.6 −0.2
B
 NY99 80 8.3±0.5 n.d. 7.2 7 0.2
 N480H 20 8.2±0.5 n.d. 6.5 6 0.5
 P38G/T1161/N480H >100,000 >18 n.d. n.d n.d n.d.
n.d.=not done.
a
Median lethal viral dose (LD50) or median protective viral dose (PD50) following intraperitoneal (i.p.) or intracerebral (i.c.) administration of 
virus. AST=average survival time.
b
Virus seeds were plaque titrated in Vero cells under agar overlay at 37 °C and 41 °C. The relative change [log10 (titer at 41 °C/titer at 37 °C)] in 
viral titer at the higher temperature indicates the degree of temperature sensitivity.
c
Infectious clone-derived wild-type WNV, strain NY99, central hydrophobic mutants, and N-terminal mutants in NS4B were tested. 
D35E=aspartic acid-to-glutamic acid mutation at amino acid residue NS4B-38.
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Table 2
Viremia and brain titers from mice inoculated with 100 pfu of either wild-type WNV or P38G/T116I/N480H 
mutant virus via the intraperitoneal route.











2 5.0±0.5 – 3.1±0.2 –
3 2.5±0.3 – 2.3±0.6 –
4 2.1±0.1 4.3±0.3 2.0b –
5 – 5.1±0.8 – –
6 – 6.8±0.6 – –
a
No virus detected. The limits of detection were 1.7 log10pfu/mL in the serum and 2.7 log10pfu/brain.
b
Only one of three mice had detectable infectivity.
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Table 3











41 °C (log10 pfu)
Relative change in viral titer
[log10(pfu41C/pfu37C]
i.p. LD50 (pfu) i.p. AST (days±SD)
NY99 7.2 7.0 −0.2 0.7 7.2±0.4
P38G/T116I/
 N480H
6.7 3.4 −3.3 >10,000,000 >35
+A83S 4.7 3.4 −1.3 >1000 >21
+A95T 5.0 4.6 −0.4 2.0 8.8±0.8
+A100V 5.5 5.1 −0.4 8.0 11±1.2
+V110A 5.1 4.7 −0.4 4.0 9.6±1.3
+I224V 4.6 4.3 −0.3 5.0 11±2.0
a
Virus seeds were plaque titrated in Vero cells under agar overlay at 37 °C and 41 °C. The relative change [log10 (titer at 41 °C/titer at 37 °C)] in 
viral titer at the higher temperature indicates the degree of temperature sensitivity.
b
Median lethal viral dose (LD50) following intraperitoneal (i.p.) administration of virus. AST=average survival time.
c
Infectious clone-derived wild-type NY99 WNV, attenuated P38G/T116I/N480H virus, and P38G/T116I/N480H-derived viruses encoding 
additional amino acid substitutions. +A83S=alanine-to-serine mutation at amino acid residue NS4B-83 in addition to NS4B P38G, T116I , and NS3 
N480H substitutions.
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Table 4
Analysis of the mutation rate of the NS4B gene of P38G/T116I/N480H virus during replication in Vero cells 
at either 37 °C or 41 °C compared to sequence variability in the parental stock.
cDNA
clone no.
b Parental P38G/T116I virus
a 37 °C 96-hour virus 41 °C 96-hour virus
Nucleotide change Amino acid change Nucleotide change Amino acid change Nucleotide change Amino acid change




2 – – – – T7015C, C7214T* A100V
3 T7015C – G7564A* V217I G7198A* A95T
4 – – G7080A – G7198A*, T7488C, A7554G A95T
5 C7087T* H58Y – – G7198A* A95T
6 – – – – G7198A* A95T
7 – – G7080A, A7240G*, A7648G* T109A, I245V G7198A* A95T
8 – – – – G7198A* A95T
9 – – – – G7198A* A95T
10 – – A7218G – G7198A* A95T
11 – – – – C7214T*, A7227G A100V
12 – – – – T7015C, C7214T*, T7594C* A100V, C227R
13 – – – – G7166A* R84Q
14 – – A7481G* N189S G7198A* A95T
15 – – – – G7198A*, C7410T, A7417G* A95T, I168V
16 – – – – A7005G, G7198A*, T7488C A95T
17 – – – – A7585G* I224V
18 – – A7240G*, A7648G* T109A, I245V G7198A* A95T
19 – – – – G7198A* A95T
20 – – T7262C*, A7444T* I116T, M177L A7057G*, C7214T* T48A, A100V
21 A7554G – – – – –
22 – – N.A. N.A. A7585G* I224V
23 N.A. N.A. N.A. N.A. T7056C*, G7198A* L56P, A95T
*
=nucleotide mutation(s) that encode the shown amino acid mutation(s).
a
Parental virus passaged once in Vero cells following the initial derivation by transfection.
b
RT-PCR-amplified cDNA containing the NS4B gene was cloned into a plasmid vector in E. coli. The nucleotide sequences of 21 or 23 individual 
NS4B clones were analyzed for the presence of non-engineered mutations.
c
–=no nucleotide mutation detected in the cloned NS4B gene fragment.
d
=nucleotide mutation(s) that encode the shown amino acid mutation(s).
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